on October 22, 2025 at 4:43 am China’s Innovent Strikes Cancer Drug Deal With Takeda for Up to $11.4 Billion​Jason Chau

The tie-up is the latest between Chinese companies and international pharma majors looking to expand their global reach and tap promising drug pipelines developing in China.